akebia

  1. Amgen revisiting Akebia buyout

    Amgen BD looking to salvage the revenue being lost from its EPO business. Both Vifor and Davita (converting fast from Epogen to Mircera) are using Roche product. Its best and the only option is Vafseo, which also has better labeling than GSK oral product, and also touts existing partnership with...
  2. Horizon or Akebia

    Entertaining an offer for a RSS role at Akebia. I’ve been working for Horizon in the primary care space for 6 years. Any advice as to whether I should pursue the new company?